Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

56.88 -1.30 (-2.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
34 35 Next >
News headline image
Why We Buy Stocks ↗
Is fear of missing out (FOMO) controlling your portfolio? 
Via The Motley Fool
News headline image
3 Bargain Stocks to Buy in a Market That's Priced for Perfection ↗
Yes, bargains can still be found in the stock market. 
Via The Motley Fool
News headline image
Why I Keep Buying These 14 Incredible Growth Stocks ↗
This diverse set of growth stocks offers tremendous opportunities in the fields of AI, space, biotech, and emerging industries. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Is CRISPR Therapeutics Stock a Buy? ↗
The markets this biotech is looking to enter could be extremely lucrative. 
Via The Motley Fool
News headline image
2 Biotech Stocks That Are Screaming Buys This Month ↗
They won't remain southbound forever. 
Via The Motley Fool
News headline image
This Healthcare Growth Stock Could Be a Steal of a Deal Right Now ↗
CRISPR Therapeutics is trading around multiyear lows. 
Via The Motley Fool
News headline image
These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer ↗
Market-beating returns could be on the way for patient investors in these two up-and-coming healthcare growth stocks. 
Via The Motley Fool
News headline image
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. ↗
Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths. 
Via Investor's Business Daily
News headline image
3 Dirt Cheap Stocks to Buy Right Now ↗
Bargain hunters should love these great stocks. 
Via The Motley Fool
News headline image
Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy? ↗
There's a lot of growth on the way, and soon. 
Via The Motley Fool
News headline image
1 Biotech Stock Down 62% to Buy and Hold ↗
It's an excellent opportunity to buy shares of what could become a biotech giant on the dip. 
Via The Motley Fool
News headline image
3 No-Brainer Biotech Stocks to Buy With $200 Right Now ↗
An investment in these players today could score a big win down the road. 
Via The Motley Fool
News headline image
Looking for Stock Bargains With Room to Run? Try This. ↗
Investing tips from Bill Mann, The Motley Fool's director of small-cap research. 
Via The Motley Fool
News headline image
Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal? ↗
Is the potential upside for CRISPR Therapeutics too massive to ignore? 
Via The Motley Fool
News headline image
3 Monster Biotech Stocks to Buy Before 2025 ↗
These companies are nearly in the sweet spot of risk versus reward in biotech. 
Via The Motley Fool
News headline image
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 ↗
The companies are chasing major innovations. 
Via The Motley Fool
News headline image
Got the Market Sell-Off Blues? Do These 3 Things Right Now ↗
You aren't powerless in the face of what the market throws at you. 
Via The Motley Fool
News headline image
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom ↗
The "Mad Money" host says Dexcom had "a real bad miss... they still really haven't fully explained why that is." 
Via Benzinga
News headline image
7 Biotech Stocks to Buy for Their Game-Changing Potential ↗
Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks. 
Via InvestorPlace
News headline image
The 3 Best Gene Editing Stocks to Buy in August 2024 ↗
These are the best gene-editing stocks to buy as the biotechs pursue precision therapies to cure rare diseases. 
Via InvestorPlace
News headline image
Is It Too Late to Buy Vertex Pharmaceuticals Stock? ↗
Shares of the rare disease drugmaker are already up more than 40% over the past year. 
Via The Motley Fool
News headline image
CRSP Stock Earnings: CRISPR Therapeutics Beats EPS, Misses Revenue for Q2 2024 ↗
CRSP stock results show that CRISPR Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030 ↗
Great companies are found in every type of market landscape. 
Via The Motley Fool
News headline image
Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker ↗
The biotech recently became a commercial-stage company. 
Via The Motley Fool
News headline image
3 Unstoppable Stocks to Buy in August ↗
It's not hard to envision how all three of these stocks can deliver exceptional growth. 
Via The Motley Fool
News headline image
10 Best Small and Mid-Cap Stocks to Consider Buying in August ↗
A shift in market dynamics could favor these 10 growth stocks. 
Via The Motley Fool
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The strugglingh stock investor did a little bit of shopping on Tuesday, adding to some of her existing positions. 
Via The Motley Fool
News headline image
The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024 ↗
The investing guru likes to take the pulse of where the world will be tomorrow and these Cathie Wood stocks reflect that vision. 
Via InvestorPlace
News headline image
3 Small-Cap Stocks to Buy at a 52-Week Low ↗
The Russell 2000 is hinting at sector rotation, meaning it’s time for bargain hunters to look for small-cap stocks at 52-week lows 
Via InvestorPlace
News headline image
3 Gene Editing Stocks Shaping the Future of Medicine ↗
Gene editing stocks offer a bold venture into biopharma's future, leveraging CRISPR technology for transformative healthcare solutions 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.